Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-150
Closed -$797 783
2024
Q4
$797 Buy
+150
New +$754 ﹤0.01% 832
2024
Q3
Sell
-150
Closed -$1.07K 856
2024
Q2
$1.07K Hold
150
﹤0.01% 838
2024
Q1
$1.28K Hold
150
﹤0.01% 821
2023
Q4
$890 Buy
150
+50
+50% +$436 ﹤0.01% 806
2023
Q3
$992 Hold
100
﹤0.01% 850
2023
Q2
$1.76K Hold
100
﹤0.01% 797
2023
Q1
$2.26K Hold
100
﹤0.01% 795
2022
Q4
$2K Hold
100
﹤0.01% 815
2022
Q3
$6K Buy
100
+50
+100% +$3.31K ﹤0.01% 693
2022
Q2
$3K Hold
50
﹤0.01% 760
2022
Q1
$4K Hold
50
﹤0.01% 753
2021
Q4
$4K Buy
+50
New +$5.35K ﹤0.01% 755

Other funds holding CLNN

Washington Trust's CLNN Position: Q1 2025 in Review

Washington Trust sold out of Clene (CLNN) in Q1 2025, closing a stake of 150 shares — an estimated $797 sold.

Washington Trust first reported a position in CLNN in Q4 2021 and held it in 12 quarters. The position peaked at $6K in Q3 2022. 24 funds tracked by Wall St. Rank hold CLNN as of Q1 2025.

  • Washington Trust reported no remaining Clene position as of Q1 2025 after selling out during the quarter.
  • Washington Trust sold 150 Clene shares in Q1 2025, an estimated $797.
  • Washington Trust first reported a position in Clene in Q4 2021 and held it in 12 quarters.
  • Washington Trust's Clene position peaked at $6K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held Clene as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.